LEADER 05212nam 2200649 450 001 9910824129203321 005 20230803220351.0 010 $a1-61705-094-6 035 $a(CKB)2550000001140408 035 $a(EBL)1531544 035 $a(OCoLC)862372362 035 $a(SSID)ssj0001040716 035 $a(PQKBManifestationID)12452248 035 $a(PQKBTitleCode)TC0001040716 035 $a(PQKBWorkID)11001760 035 $a(PQKB)10850689 035 $a(MiAaPQ)EBC1531544 035 $a(Au-PeEL)EBL1531544 035 $a(CaPaEBR)ebr10794246 035 $a(CaONFJC)MIL539922 035 $a(EXLCZ)992550000001140408 100 $a20111102h20142014 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aHeart failure $ea case-based approach /$feditor, Peter Ranko 210 1$aNew York :$cDemos Medical Publishing,$d[2014] 210 4$dİ2014 215 $a1 online resource (281 p.) 300 $aDescription based upon print version of record. 311 $a1-936287-51-X 311 $a1-306-08671-X 320 $aIncludes bibliographical references and index. 327 $aCover; Title Page; Copyright Page; Contents; Contributors; Preface; Video Captions; Part I: Newly Diagnosed Heart Failure; 1. Initial Presentation of Heart Failure: The Non-Ischemic Dilated Cardiomyopathy; Case Presentation; Symptoms and Signs of Heart Failure; ECG, Chest X-Ray, Laboratory Exam; Natriuretic Peptide Biomarkers; Echocardiography; Evaluation for Coron Aryartery Disease; Medical Treatment of Heart Failure; Conclusion; References; 2. Patient with Heart Failure Following a Large Myocardial Infarction; Case Presentation; Post-Myocardial Infarction Care; Risk Stratification 327 $aComorbiditiesSocial Determinants in Heart Failure; Potential for Cardiac Function Recovery; Device Therapies for Heart Failure; References; 3. Tako-Tsubo (Stress) Cardiomyopathy; Case Presentation; Approach to the Patient; Imaging; Hospital Management; Congestive Heart Failure; Ventricular Thrombus; Arrhythmia and ECG Evolution; Posthospital Management; Bibliography; 4. Atrial Fibrillation and Cardiomyopathy with Heart Failure; Introduction; Case 1: Atrial Fibrillation as a Result of Patient Noncompliance; Case 2: Atrial Fibrillation Causing Tachycardia-Mediated Cardiomyopathy 327 $aCase 3: Atrial Fibrillation Complicating Infiltrative Cardiomyopathy with Preserved Left Ventricular Ejection Fraction-AmyloidosisSummary; References; 5. Heart Failure with Preserved Ejection Fraction (HFPEF): A Common Sense Approach; Introduction; HFPEF Epidemiology; Pathophysiology; Nomenclature; Normal Diastole Physiology; Abnormalities of Diastole with HFPEF; Case Presentation; Definition and Diagnosis of HFPEF; Case Continuation; Physiological Consideration of HFPEF; Acute Presentation, Evaluation, and Management of HFPEF; Current Diagnostic Criteria for HFPEF 327 $aDoppler Echocardiography and HFPEFHospital to Home Challenges in HFPEF; Beyond Hospital to Home Transitions in Care; Targeted Therapies for HFPEF; Emerging Therapies for HFPEF; Conclusion; References; Part II: Optimizing Therapy for Patients with Chronic Heart Failure; 6. Acute Decompensated Heart Failure in the Previously Stable Heart Failure Patient: A Practical Guide to Evaluation and Treatment; Case Presentation; Acute Decompensated Heart Failure; Determining the Etiology; Optimal Treatment; Preventing Readmission; References 327 $a7. Optimizing Heart Failure Management in Idiopathic Non-Ischemic Dilated Cardiomyopathy Complicated by Ventricular ArrhythmiaThe Clinical Problem; Case Highlights; Problem of QRS Widening in the Heart Failure Patient; Role of Cardiac Resynchronization; Syncope in NIDCM; Prevention of Sudden Cardiac Death in NIDCM; Management of Recurrent Ventricular Arrhythmias in NIDCM; Summary; References; 8. Cardiac Resynchronization Therapy in Heart Failure; Introduction; Background; Mechanisms; Clinical Trial Data in Moderate Severe Heart Failure; Clinical Trial Data in Mild to Moderate Heart Failure 327 $aMajor Society Guidelines 330 $aHeart failure is defined as the weakening of the heart's pumping power, and that it is unable to adequately supply the body with oxygen and nutrients. As the heart weakens it tends to stretch and stiffen under the stress. The kidneys respond by causing the body to retain fluid. If fluid builds up in the arms, legs, ankles, feet, lungs, or other organs, the body becomes congested, and congestive heart failure is the term used to describe the condition. Heart failure is the result of heart damage that can be caused by a number of diseases, including coronary artery disease, cardiomyopathy, atria 606 $aHeart failure$vCase studies 606 $aHeart failure$xResearch 615 0$aHeart failure 615 0$aHeart failure$xResearch. 676 $a616.1 676 $a616.1/29 676 $a616.129 701 $aRanko$b Peter$01599781 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910824129203321 996 $aHeart failure$93922626 997 $aUNINA